Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-01 · accession 0001193125-25-314652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-10 | 2025-12-01 | SRPT | Wong Ryan Ho-Yan | CFO | F - Tax | $20.96 | -158 | 136.0K | -0.1% | -$3,312 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | F | D | 80 | $20.96 | 136,123 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021. |
| 2 | Common | Common Stock | 2025-12-01 | F | D | 78 | $20.96 | 136,045 | D | — | — | (F2) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2022. |